Nonsteroidal Topical Gets FDA Approval for Psoriasis

A new nonsteroidal agent, tapinarof cream 1%, is approved for adults with plaque psoriasis based on studies showing a high degree of efficacy and minimal risk of adverse events with daily use. New Drugs: Tapinarof Cream By Ted Rosen, MD Tapinarof Cream 1% (Vtama, Dermavant) was recently FDA approved to treat mild, moderate, or severe plaque […]